[Therapeutic consequences of the circadian rhythm. Which measures against early-morning myocardial ischemia?].
Michel
D
D
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002940:Circadian Rhythm; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D005996:Nitroglycerin
Therapeutische Konsequenzen der zirkadianen Rhythmik. Welche Massnahmen gegen frühmorgendliche myokardiale Ischämien?